/ 100
Nectar Lifesciences Limited (NECLIFE) — Technical Setup
₹10.98 -0.36% Range Normal Volatility Strong bearish
Summary
Nectar Lifesciences Limited is in a range on the daily chart, with the weekly trend bearish and the monthly trend bearish. RSI(14) is 41.4, MACD is below its signal line, ADX reads 13 (weak trend). The stock trades 15.9% below its 200-day average and 51.0% below its 52-week high. Volume in the latest session was 0.3× its 20-day average. Over three months it has underperformed the Nifty 50 by 2.6 percentage points. Nearest support is ₹10.05 and resistance ₹11.77. Its technical score is 19/100 (strong bearish).
🧮 How the 19/100 is built
Five components, 20 points each. Every rule is shown with the points it earned — the score describes the chart as it stands today; it is not a prediction.
- Close above 20-day EMA (-4.56)0/3
- 20-day EMA above 50-day EMA3/3
- 50-day EMA above 200-day EMA0/3
- Close above 200-day SMA (-15.94)0/3
- SuperTrend (10,3) pointing up0/3
- ADX ≥ 20 with +DI above −DI (trend has strength) (12.93)1/3
- Weekly trend up (above a rising 30-week average)0/2
- RSI(14) in the bullish zone (55-70 best) (41.40)2/6
- MACD line above its signal line0/4
- MACD line above zero (-0.03)0/3
- 12-day rate of change positive (-10.80)0/3
- Stochastic %K above %D2/2
- Outperforming the Nifty 50 over 3 months (-2.60)0/2
- On-balance volume rising over 20 sessions0/5
- Chaikin Money Flow (20) positive (-0.07)0/5
- More volume on up days than down days (20 sessions) (1.96)5/5
- Close above 20-day VWAP (-10.00)0/5
- Daily range (ATR%) contained — ≤2.5% scores full (5.00)2/6
- Price in the upper half of its Bollinger Bands (0.15)0/5
- Shallow drawdown from the 52-week high (-50.98)0/5
- Volatility contracting (20-day volatility below its 6-month median) (68.80)0/4
- Room to the next resistance (≥8% scores full) (7.19)3/5
- Support close below (a tight, definable stop) (8.47)1/5
- Broke above a 20-day high in the last 5 sessions0/5
- Within 5% of the 52-week high (-50.98)0/5
🧭 Regime: Range
Normal Volatility — Bollinger width is in the 67th percentile of the last six months.
Suits: Mean reversion / range trading. No directional edge: buy near range support, sell near resistance, and treat breakouts with suspicion until volume confirms them.
Classified from ADX, the 20/50-day EMA stack and price's distance from the 50-day average; volatility from band-width and ATR expansion.
Opens the AI Backtester with the Bollinger Band Reversion rules for NECLIFE — close below the lower bollinger band (20,2) while above the 200-day sma.
🕰️ Multi-timeframe
| Timeframe | Trend | RSI (14) | MACD hist. |
|---|---|---|---|
| Monthly | ▼ Bearish | 57.40 | -0.05 |
| Weekly | ▼ Bearish | 44.06 | 0.20 |
| Daily | ◆ Neutral | 41.40 | -0.17 |
Weekly: close vs a rising 30-week average (Weinstein). Monthly: close vs the 10-month average. Weekly SuperTrend: Bullish, weekly ADX 14.38.
📶 Volume & VWAP
VWAPs are computed from daily bars (typical price × volume), not intraday ticks. Volume has dried up to under 60% of normal.
💪 Relative strength
NECLIFE ÷ Nifty 50, rebased to 100 a year ago. Rising = outperforming.
🧱 Support & resistance
Clustered swing highs and lows from the last year; “touches” is how many swings formed the level.
| Level | Price | Distance | Touches |
|---|---|---|---|
| Resistance | ₹13.93 | +26.9% | 1 |
| Resistance | ₹13.51 | +23.0% | 2 |
| Resistance | ₹13.03 | +18.7% | 5 |
| Resistance | ₹11.77 | +7.2% | 5 |
| Close | ₹10.98 | — | |
| Support | ₹10.05 | −8.5% | 3 |
| Support | ₹9.30 | −15.3% | 1 |
52-week range: ₹9.30 – ₹22.40 (-50.98% from the high).
🌀 Fibonacci
Measuring the up-swing from ₹9.30 (2026-03-30) to ₹14.91 (2026-05-08). Price has retraced 70.0% of it.
| Ratio | Price | Distance | |
|---|---|---|---|
| 23.6% retracement | ₹13.59 | +23.7% | S/R confluence |
| 38.2% retracement | ₹12.77 | +16.3% | |
| 50.0% retracement | ₹12.11 | +10.2% | |
| 61.8% retracement | ₹11.44 | +4.2% | nearest |
| 78.6% retracement | ₹10.50 | -4.4% | |
| 127.2% extension | ₹16.44 | +49.7% | |
| 161.8% extension | ₹18.38 | +67.4% | |
| 200.0% extension | ₹20.52 | +86.9% |
🕯️ Candlesticks (last 5 sessions)
No classic candlestick pattern in the last five sessions.
↗️ Divergences
No regular divergence on RSI, MACD, OBV, MFI or Stochastic at the latest swings.
✅ Screens NECLIFE passes today
| Stock | Close | Chg | Score | Trend regime | RS rating (1-99) |
|---|---|---|---|---|---|
| AUROPHARMAAurobindo Pharma Limited | ₹1,734 | +2.60% | 94 | Uptrend | 84.00 |
| AAREYDRUGSAarey Drugs & Pharmaceuticals Limited | ₹102.13 | +0.40% | 85 | Strong Uptrend | 86.00 |
| ACUTAASAcutaas Chemicals Limited | ₹3,440 | +3.78% | 85 | Uptrend | 93.00 |
| KOPRANKopran Limited | ₹277.60 | +3.35% | 85 | Strong Uptrend | 96.00 |
| BAFNAPHBafna Pharmaceuticals Limited | ₹317.20 | +1.99% | 84 | Strong Uptrend | 98.00 |
| KILITCHKilitch Drugs (India) Limited | ₹191.45 | +1.47% | 84 | Uptrend | 63.00 |
| CAPLIPOINTCaplin Point Laboratories Limited | ₹2,749 | +5.85% | 83 | Uptrend | 83.00 |
| GLANDGland Pharma Limited | ₹2,962 | +1.86% | 83 | Strong Uptrend | 91.00 |
| JUBLPHARMAJubilant Pharmova Limited | ₹1,065 | +5.27% | 80 | Strong Uptrend | 64.00 |
| STARStrides Pharma Science Limited | ₹1,220 | +1.63% | 80 | Strong Uptrend | 81.00 |
⚠️ Educational technical analysis computed automatically from end-of-day NSE prices — not investment advice. Flash Finance is not SEBI-registered. Indicators describe what price has done; they do not predict what it will do. Verify levels on a live chart and manage risk before acting.
